NCT06536439

Brief Summary

A proposed new tool ('DIPLANN-tool' - Digital Planning in Nephrectomy) for predicting kidney perfusion zones on a segmented 3D model during robot-assisted partial nephrectomy (RAPN) for localized renal cancer demonstrated high accuracy when planning selective clamping (SC) for RAPN. However, the tool's clinical added value still needs to be confirmed. Therefore, a randomized controlled trial using a study and control group is the preferred study design. Experimental group: the use of the DIPLANN-tool + conventional computed tomography (CT) imaging for preoperative planning and perioperative guidance during RAPN. Control group: the use of only conventional CT imaging for preoperative planning and perioperative guidance during RAPN (= current standard of care). The primary endpoint is planning and performing as planned a SC strategy. Secondary endpoints include patients' health, patients' insight and surgeons' benefits.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
235

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jun 2024Jan 2027

Study Start

First participant enrolled

June 27, 2024

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

July 15, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 5, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

2.5 years

First QC Date

July 15, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

Kidney CancerRenal Cell CarcinomaMinimally Invasive SurgeryRobot-Assisted SurgeryRobot-Assisted Partial NephrectomyRAPN3DPerfusion Zone

Outcome Measures

Primary Outcomes (1)

  • Selective clamping

    Planning and performing as planned a selective clamping (SC) strategy (considered by the surgeon at the end of surgery, objectified pre- and postoperatively through online assessment on study website and controlled through video-analysis): planning SC and performing the planned SC strategy = positive outcome; planning SC and performing another SC strategy or full clamping (FC) = negative outcome; planning FC = negative outcome.

    During surgery

Secondary Outcomes (4)

  • eGFR 6 months

    6 months postoperatively

  • Clamping strategy

    During surgery

  • Hilar dissection time

    During surgery

  • Conversion to full clamp

    During surgery

Other Outcomes (17)

  • Complications

    90 days postoperatively

  • Estimated blood loss

    During surgery

  • Perfusion model validation

    During surgery

  • +14 more other outcomes

Study Arms (2)

DIPLANN-tool + conventional CT imaging

EXPERIMENTAL

Pre-operative planning and peri-operative guidance with DIPLANN-tool and conventional CT imaging.

Device: Pre-operative explanation of the procedure (DIPLANN + CT)Device: Pre-operative surgical planning (DIPLANN + CT)Procedure: RAPN (DIPLANN + CT)

Conventional CT imaging alone

ACTIVE COMPARATOR

Pre-operative planning and peri-operative guidance with conventional CT imaging alone (standard of care).

Device: Pre-operative explanation of the procedure (CT only)Device: Pre-operative surgical planning (CT only)Procedure: RAPN (CT only)

Interventions

Pre-operative study visit explaining the RAPN procedure using the 3D model / DIPLANN-tool (with or without classical CT imaging). Included in this visit is a pre-operative physical examination (height, weight, abdominal examination), pre-operative blood examination (Hb, creatinin, eGFR) and patient questionnaires regarding patient knowledge, patient anxiety and patient quality of life.

DIPLANN-tool + conventional CT imaging

Online assessment by surgeon regarding clamping strategy. Assisted by DIPLANN-tool + CT scan.

DIPLANN-tool + conventional CT imaging

Robot-assisted partial nephrectomy surgical procedure. Peri-operative guidance by DIPLANN-tool + CT scan.

DIPLANN-tool + conventional CT imaging

Pre-operative study visit explaining the RAPN procedure using CT imaging alone. Included in this visit is a pre-operative physical examination (height, weight, abdominal examination), pre-operative blood examination (Hb, creatinin, eGFR) and patient questionnaires regarding patient knowledge, patient anxiety and patient quality of life.

Conventional CT imaging alone

Online assessment by surgeon regarding clamping strategy. Assisted by classical CT imaging only.

Conventional CT imaging alone

Robot-assisted partial nephrectomy surgical procedure. Peri-operative guidance by CT imaging only.

Conventional CT imaging alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years or above
  • cT1-2 N0 M0 renal mass
  • planned to undergo RAPN
  • multiphase CT scan with arterial phase available
  • voluntary given and written informed consent
  • sufficient in at least one of the study languages: Dutch, English, French

You may not qualify if:

  • \> 3 ipsilateral renal masses
  • women who are pregnant or breastfeeding
  • previous renal surgery that is expected to complicate renal cancer surgery
  • cT ≥ 3
  • planned off-clamp resection
  • cognitive disorder which impedes with completing study questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

AZORG

Aalst, 9300, Belgium

RECRUITING

AZ Sint-Jan

Bruges, 8000, Belgium

RECRUITING

ZOL

Genk, 3600, Belgium

RECRUITING

AZ Maria Middelares

Ghent, 9000, Belgium

RECRUITING

Ghent University Hospital

Ghent, 9000, Belgium

RECRUITING

Related Publications (1)

  • Vangeneugden J, Vermijs S, De Backer P, Hemeryck B, Berquin C, De Visschere P, Decaestecker K, Debbaut C, Van Praet C. Three-dimensional Perfusion-zone Models Allow More Selective Clamping During Robot-assisted Partial Nephrectomy: Brief Report on a Retrospective Analysis. Eur Urol Open Sci. 2025 Nov 5;82:128-130. doi: 10.1016/j.euros.2025.10.013. eCollection 2025 Dec.

MeSH Terms

Conditions

Kidney NeoplasmsKidney DiseasesCarcinoma, Renal Cell

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrologic DiseasesMale Urogenital DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Charles Van Praet, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joris Vangeneugden, MD

CONTACT

Charles Van Praet, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Confirmatory, multicentric, unblinded, randomized, controlled, pivotal trial using parallel group assignment and stratified randomization.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2024

First Posted

August 5, 2024

Study Start

June 27, 2024

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations